These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25988008)

  • 1. Possible effects of pramipexole on neck muscles in a patient with Parkinson's disease.
    Filippi R; Rasetti M; Lenzi M; Bright P
    Oxf Med Case Reports; 2014 Apr; 2014(1):8-10. PubMed ID: 25988008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pramipexole-induced antecollis in Parkinson's disease.
    Suzuki M; Hirai T; Ito Y; Sakamoto T; Oka H; Kurita A; Inoue K
    J Neurol Sci; 2008 Jan; 264(1-2):195-7. PubMed ID: 17826796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible antecollis associated with pramipexole in a patient with Parkinson's disease.
    Kim HJ; Jeon BS; Kim SH; Han SH
    J Clin Neurosci; 2012 Jun; 19(6):903-4. PubMed ID: 22353251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pramipexole-induced antecollis in patients with Parkinson's disease: Two cases and literature review.
    Iijima M; Osawa M; Uchiyama S; Kitagawa K
    eNeurologicalSci; 2015 Jun; 1():21-23. PubMed ID: 29468202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dropped Head Syndrome: The Importance of Neurophysiology in Distinguishing Myasthenia Gravis from Parkinson's Disease.
    Mangiardi M; Magliozzi A; Colosimo C; Marsili L
    Biomedicines; 2024 Aug; 12(8):. PubMed ID: 39200297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's disease.
    Reichmann H; Brecht MH; Köster J; Kraus PH; Lemke MR
    CNS Drugs; 2003; 17(13):965-73. PubMed ID: 14533946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term safety and efficacy of pramipexole in advanced Parkinson's disease.
    Weiner WJ; Factor SA; Jankovic J; Hauser RA; Tetrud JW; Waters CH; Shulman LM; Glassman PM; Beck B; Paume D; Doyle C
    Parkinsonism Relat Disord; 2001 Apr; 7(2):115-120. PubMed ID: 11248592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency and range of sexual behavior in a patient with Parkinson's disease after use of pramipexole: a case report.
    Munhoz RP; Fabiani G; Becker N; Teive HAG
    J Sex Med; 2009 Apr; 6(4):1177-1180. PubMed ID: 18466265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.
    Dooley M; Markham A
    Drugs Aging; 1998 Jun; 12(6):495-514. PubMed ID: 9638397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of pramipexole in Parkinson's disease in the US.
    Hoerger TJ; Bala MV; Rowland C; Greer M; Chrischilles EA; Holloway RG
    Pharmacoeconomics; 1998 Nov; 14(5):541-57. PubMed ID: 10344917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
    Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
    Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness.
    Noyes K; Dick AW; Holloway RG;
    Pharmacoeconomics; 2005; 23(12):1257-70. PubMed ID: 16336019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group.
    Shannon KM; Bennett JP; Friedman JH
    Neurology; 1997 Sep; 49(3):724-8. PubMed ID: 9305331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease.
    Bennett JP; Piercey MF
    J Neurol Sci; 1999 Feb; 163(1):25-31. PubMed ID: 10223406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pramipexole Overdose Associated with Visual Hallucinations, Agitation and Myoclonus.
    Cardon-Dunbar A; Robertson T; Roberts MS; Isbister GK
    J Med Toxicol; 2017 Dec; 13(4):343-346. PubMed ID: 28547577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of elderly onset Parkinson's disease complicated by dropped head syndrome].
    Horiuchi M; Uehara K; Komo T; Sugihara H; Takahashi Y
    Nihon Ronen Igakkai Zasshi; 2001 Sep; 38(5):693-5. PubMed ID: 11605221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and clinical correlates of retrocollis in Parkinson's disease.
    Kashihara K; Imamura T
    J Neurol Sci; 2013 Jan; 324(1-2):106-8. PubMed ID: 23151424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of pramipexole, a new dopamine receptor agonist, to relieve the parkinsonian-like muscle rigidity in rats.
    Lorenc-Koci E; Wolfarth S
    Eur J Pharmacol; 1999 Nov; 385(1):39-46. PubMed ID: 10594343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotigotine transdermal system for the treatment of Parkinson's disease.
    Pham DQ; Nogid A
    Clin Ther; 2008 May; 30(5):813-24. PubMed ID: 18555929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal behaviours during pramipexole treatment for Cotard's syndrome: a case report.
    Maruo J; Haraguchi Y; Tateishi H; Noguchi T; Mizoguchi Y; Kato TA; Kawashima T; Monji A
    Psychogeriatrics; 2016 Jul; 16(4):283-286. PubMed ID: 26419319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.